BISCAGLIA, Simone
 Distribuzione geografica
Continente #
NA - Nord America 8.124
AS - Asia 4.924
EU - Europa 2.924
SA - Sud America 953
AF - Africa 99
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 17.064
Nazione #
US - Stati Uniti d'America 7.886
SG - Singapore 2.131
CN - Cina 1.223
BR - Brasile 804
DE - Germania 698
HK - Hong Kong 516
IT - Italia 498
VN - Vietnam 309
FI - Finlandia 308
GB - Regno Unito 308
PL - Polonia 193
TR - Turchia 188
FR - Francia 173
SE - Svezia 157
UA - Ucraina 157
RU - Federazione Russa 143
ID - Indonesia 124
CA - Canada 110
IN - India 106
MX - Messico 106
JP - Giappone 66
AR - Argentina 56
ES - Italia 54
NL - Olanda 51
ZA - Sudafrica 49
BD - Bangladesh 37
BE - Belgio 36
AT - Austria 35
AU - Australia 35
KR - Corea 33
IQ - Iraq 30
CO - Colombia 26
IR - Iran 24
LT - Lituania 23
EC - Ecuador 22
PK - Pakistan 21
EG - Egitto 18
CZ - Repubblica Ceca 16
CH - Svizzera 15
MY - Malesia 14
VE - Venezuela 12
TH - Thailandia 11
TW - Taiwan 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
CL - Cile 8
IE - Irlanda 8
IL - Israele 8
PT - Portogallo 8
KE - Kenya 7
PE - Perù 6
PS - Palestinian Territory 6
SA - Arabia Saudita 6
TN - Tunisia 6
UY - Uruguay 6
CY - Cipro 5
DK - Danimarca 5
JM - Giamaica 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HR - Croazia 4
MA - Marocco 4
RO - Romania 4
BG - Bulgaria 3
BH - Bahrain 3
DZ - Algeria 3
JO - Giordania 3
KG - Kirghizistan 3
KW - Kuwait 3
LI - Liechtenstein 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
PH - Filippine 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AQ - Antartide 1
BB - Barbados 1
Totale 17.048
Città #
Ashburn 1.119
Singapore 1.067
Fairfield 754
Woodbridge 562
Hong Kong 496
Beijing 459
Munich 441
Santa Clara 441
Houston 437
Chandler 334
Seattle 316
Ann Arbor 298
Wilmington 289
Cambridge 265
Dallas 242
Los Angeles 213
New York 188
Helsinki 183
Jacksonville 183
Warsaw 181
Ho Chi Minh City 106
São Paulo 99
Shanghai 98
Princeton 96
Izmir 94
Milan 89
Jakarta 83
Nanjing 82
London 77
Ferrara 75
Turku 71
San Diego 64
Mexico City 61
Chicago 56
Tokyo 55
Hanoi 53
Brooklyn 51
Atlanta 43
Stockholm 40
Frankfurt am Main 39
Buffalo 38
Boston 37
Hefei 37
Brussels 36
Chennai 36
Montreal 36
Nuremberg 36
Denver 33
Orem 33
Moscow 32
Poplar 31
Boardman 30
Bremen 29
Johannesburg 29
Falls Church 28
Toronto 27
Mumbai 26
Phoenix 26
San Francisco 24
Tianjin 24
Nanchang 22
Rio de Janeiro 22
The Dalles 22
Manchester 21
Salt Lake City 21
Redwood City 19
Amsterdam 18
Columbus 18
Melbourne 18
Ankara 17
Bologna 17
Council Bluffs 17
Shenyang 17
Belo Horizonte 16
Des Moines 16
Jiaxing 16
Norwalk 16
Changsha 15
Dong Ket 15
Redondo Beach 15
Washington 15
Falkenstein 14
Haiphong 14
Hebei 14
Augusta 13
Biên Hòa 13
Da Nang 13
Jyväskylä 13
Ottawa 13
Assago 12
Brasília 12
New Delhi 12
Paris 12
Querétaro 12
Addison 11
Bangkok 11
Quito 11
Curitiba 10
Guangzhou 10
Baghdad 9
Totale 11.130
Nome #
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 383
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 370
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 334
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 295
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 277
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 253
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 252
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 232
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 231
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 228
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 228
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 223
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 222
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 203
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 203
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 202
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 201
Uric acid and coronary artery disease: An elusive link deserving further attention 199
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 193
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 192
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Can we improve myocardial protection during ischaemic injury? 185
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 185
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 177
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 177
BRS implantation in long lesions requiring device overlapping: Myth or reality? 176
Angina and left ventricular dysfunction: can we "reduce' it? 176
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 175
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 174
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 170
Fractional flow reserve: Current applications and overview of the available data 169
Reperfusion Damage - A Story of Success, Failure, and Hope 169
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 169
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 167
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 156
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 153
Fractional flow reserve implementation in daily clinical practice: A European survey 152
Angina and chronic obstructive pulmonary disease: facing the perfect storm 152
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 150
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 149
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 149
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 146
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 142
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 142
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 142
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter “real-world” registry 141
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 141
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 139
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 135
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 131
Transradial coronary catheterization and intervention across the whole spectrum of Allen test results 131
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 129
Coronary Physiology Guidance vs. Conventional Angiography for Optimization of Percutaneous Coronary Intervention: the AQVA II Trial 128
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis: A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) 128
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 127
Remodelling after an Infarct: Crosstalk between Life and Death 123
Enhanced stent visualization systems during PCI: A case series and review of literature 123
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 122
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry 121
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 120
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 119
Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease 119
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 119
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 118
Impact of trans-stent gradient on outcome after PCI: results from a HAWKEYE substudy 117
Functional Assessment and Acute Coronary Syndrome 114
Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies 114
Seven french radial artery access for PCI: A prospective single-center experience 112
QFR-Based Virtual PCI or Conventional Angiography to Guide PCI: The AQVA Trial 111
Age and Outcomes in TAVR Patients: Are We Barking Up the Wrong Tree? 107
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 106
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 105
Coronary Computed Tomography Angiography for the Assessment of Sirolimus-Eluting Resorbable Magnesium Scaffold 104
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 104
Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm 103
Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19 103
#FullPhysiology: a systematic step-by-step guide to implement intracoronary physiology in daily practice 101
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 101
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 100
Neural interfaces to monitor Interventional Cardiologists' mental workload: GAME-ON SAGA 98
null 94
Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis 93
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 92
Complete vs. culprit-only strategy in older MI patients with multi-vessel disease 92
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 92
The impact of periprocedural myocardial infarction on mortality in older adults with non-ST-segment elevation acute coronary syndrome: a pooled analysis of the FRASER and HULK studies 91
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 90
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study 90
QFR for the Revascularization of Nonculprit Vessels in MI Patients: Insights From the FIRE Trial 88
What are the recommendations for adding novel oral anticoagulants to P2Y12-receptor inhibitors, with or without aspirin? 86
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 83
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 83
Comparison of quantitative flow ratio, Pd/Pa, and diastolic hyperaemia-free ratio vs. fractional flow reserve in non-culprit lesion of patients with non-ST-segment elevation myocardial infarction 82
Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study 81
Complete or Culprit-Only PCI in Older Patients with Myocardial Infarction 80
CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE ASSESSMENT OF SIROLIMUS-ELUTING RESORBABLE MAGNESIUM SCAFFOLD 80
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 79
Combined use of intra-aortic balloon pump and impella in cardiogenic shock: A systematic review 78
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial 78
Totale 14.920
Categoria #
all - tutte 90.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021833 0 0 0 0 0 79 66 167 62 174 192 93
2021/20221.041 106 96 78 43 46 58 56 72 45 78 124 239
2022/2023876 105 55 50 69 128 120 69 72 120 8 58 22
2023/2024899 48 68 36 19 64 147 53 96 23 59 76 210
2024/20254.596 112 104 281 238 507 449 338 270 820 451 565 461
2025/20265.697 1.045 464 1.003 1.403 1.663 119 0 0 0 0 0 0
Totale 17.509